Amy Brown on Muck Rack

Amy Brown

News Editor, EP Vantage

Pharma and biotech reporter, found a home at EP Vantage.

Search Tweets

Twitter Feed

@ByAmyBrown — 818 followers, 634 tweets

Aug 22, 2017

Up for grabs or on the shelf? Our look at the sellside's most valuable, unpartnered R&D assets:  http://ow.ly/PX5k30eATTd  $KTE $DBVT $AXON

Aug 22, 2017

RT @EPVantage: Vantage Snippet – Alexion muscles in on new market $ALXN https://t.co/nXJNMAFzqY

Aug 22, 2017

RT @EPVantage: Vantage Snippet - Samsung looks beyond biosimilars with Takeda deal $TKPYY https://t.co/P9kokmNLno

Aug 17, 2017

RT @EPVantage: Vantage Snippet - Advair generic substitutability and timing take centre stage again $HKMPY $MYL https://t.co/bOMZGvVOQE

Aug 16, 2017

@portefeuillefun @evaluatepharma EU/big pharma analyst conservatism vs US/biotech analyst bullishness? Definitely makes a difference on value of similar assets

Show more